Psychedelic therapy has been gaining not only popularity but acceptance in the medical community in recent years. New evidence suggests even a single-dose treatment of psilocybin, the active ingredient in magic mushrooms, can have “immediate, substantial, and sustained improvements” in a number of different illnesses of both the mind and body.
Research on psychedelic pharmacological compounds in the 1950s, but they were put to an abrupt halt in the 1970s. After that unplanned hiatus, Johns Hopkins became the first US research group to get regulatory approval to start looking into psychedelics again. In 2018, the United States’ oldest research university, launched the Johns Hopkins Center for Psychedelic and Consciousness Research.
Combatting addiction with psilocybin and music
This particular study looked into the treatment of smoking addiction, with the goal that by the end of the study, patients will have adopted abstinence to nicotine. In the end, not only did the majority of patients trying to quit cigarettes prefer the overtone-based playlist; they also saw better overall outcomes of the psilocybin treatment and said they had a more mystical experience with the non-classical option.